AU5559300A - Method of making and identifying attenuated microorganisms, compositions utilizing the sequences responsible for attenuation, and preparations containing attenuated microorganisms - Google Patents
Method of making and identifying attenuated microorganisms, compositions utilizing the sequences responsible for attenuation, and preparations containing attenuated microorganismsInfo
- Publication number
- AU5559300A AU5559300A AU55593/00A AU5559300A AU5559300A AU 5559300 A AU5559300 A AU 5559300A AU 55593/00 A AU55593/00 A AU 55593/00A AU 5559300 A AU5559300 A AU 5559300A AU 5559300 A AU5559300 A AU 5559300A
- Authority
- AU
- Australia
- Prior art keywords
- attenuated microorganisms
- attenuation
- making
- preparations containing
- identifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1065—Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/32—Mycobacterium
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14298299P | 1999-07-06 | 1999-07-06 | |
US60142982 | 1999-07-06 | ||
US14283399P | 1999-07-08 | 1999-07-08 | |
US60142833 | 1999-07-08 | ||
PCT/IB2000/000950 WO2001002555A1 (en) | 1999-07-06 | 2000-07-06 | Method of making and identifying attenuated microorganisms, compositions utilizing the sequences responsible for attenuation, and preparations containing attenuated microorganisms |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5559300A true AU5559300A (en) | 2001-01-22 |
Family
ID=26840459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU55593/00A Abandoned AU5559300A (en) | 1999-07-06 | 2000-07-06 | Method of making and identifying attenuated microorganisms, compositions utilizing the sequences responsible for attenuation, and preparations containing attenuated microorganisms |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5559300A (en) |
WO (1) | WO2001002555A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7033781B1 (en) | 1999-09-29 | 2006-04-25 | Diversa Corporation | Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
EP1294869A2 (en) * | 2000-06-14 | 2003-03-26 | Diversa Corporation | Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
ATE345386T1 (en) * | 2001-05-17 | 2006-12-15 | Creatogen Ag | METHOD FOR FINDING ATTENUATED OR VIRULENT DEFECTIVE MICROBES |
WO2003008631A2 (en) * | 2001-07-20 | 2003-01-30 | Health Protection Agency | Tagging of microorganisms |
DE60219589T2 (en) * | 2002-02-25 | 2008-02-14 | Institut Pasteur | Specifically from the genome of Mycobacterium tuberculosis deleted sequences and their use in diagnostics and as a vaccine |
NZ519395A (en) * | 2002-06-07 | 2004-04-30 | Agres Ltd | Techniques for identifying genes that are important for virulence in Mycobacterial vaccines |
EP1400532A1 (en) * | 2002-09-18 | 2004-03-24 | Gerald-F. Prof. Dr. Gerlach | M. paratuberculosis specific ABC-transporter operon |
CA2732498A1 (en) * | 2008-07-30 | 2010-02-04 | Michael Strathmann | Methods for gene targeting |
WO2014144461A2 (en) * | 2013-03-15 | 2014-09-18 | Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) | Engineered organisms for production of novel lipids |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5807723A (en) * | 1987-03-02 | 1998-09-15 | Whitehead Institute For Biomedical Research | Homologously recombinant slow growing mycobacteria and uses therefor |
FR2720076B1 (en) * | 1994-05-20 | 1996-08-02 | Inst Nat Sante Rech Med | Shuttle vectors for the introduction of DNA into mycobacteria and use of these bacteria as vaccines. |
KR100445103B1 (en) * | 1994-12-09 | 2004-12-04 | 임페리얼 컬리지 이노베이션스 리미티드 | identification |
EP0910403A1 (en) * | 1996-03-27 | 1999-04-28 | The Johns-Hopkins University | Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof |
US5843664A (en) * | 1996-06-11 | 1998-12-01 | Institut Pasteur | Method of selection of allelic exchange mutants |
AU7166798A (en) * | 1997-05-06 | 1998-11-27 | Cornell Research Foundation Inc. | Dna molecule conferring on (mycobacterium tuberculosis) resistance against antimicrobial reactive oxygen and nitrogen intermediates |
US6136324A (en) * | 1997-08-21 | 2000-10-24 | Connaught Laboratories Limited | Attenuated strains of mycobacteria |
-
2000
- 2000-07-06 AU AU55593/00A patent/AU5559300A/en not_active Abandoned
- 2000-07-06 WO PCT/IB2000/000950 patent/WO2001002555A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001002555B1 (en) | 2001-06-21 |
WO2001002555A1 (en) | 2001-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6497600A (en) | Peracid forming system, peracid forming composition, and methods for making and using | |
AU1831597A (en) | Methods and compositions for inhibiting hexokinase | |
AU3898300A (en) | Methods of and compositions for treating vascular defects | |
AU2625501A (en) | Compositions and methods for gene silencing | |
AU7960200A (en) | Sealing composition and sealing method | |
AU2091499A (en) | Permeable compositions and methods for their preparation | |
AU2001219651A1 (en) | Mulch composition and method | |
ZA200007642B (en) | Treatment of airborne microorganisms. | |
AU3944497A (en) | 1,2-diarylindole as cox-2 inhibitors | |
AU2243797A (en) | Methods and compositions for inhibiting hexokinase | |
AU2002231095A1 (en) | Method and composition for the treatment of diabetic neuropathy | |
AU1278100A (en) | 2-acylamino-2-deoxy-glucono-1,5-lactones, method for obtaining same, compositions comprising them and uses | |
AU2596401A (en) | Methods and compositions for sealing tissue leaks | |
AU2747597A (en) | Method, compositions and kit for detection and identification of microorganisms | |
MXPA01011182A (en) | Methods, compositions and kits for biological indicator of sterilization. | |
AU5029700A (en) | Glycopeptide antibacterial compounds, compositions containing same and methods of using same | |
AU5559300A (en) | Method of making and identifying attenuated microorganisms, compositions utilizing the sequences responsible for attenuation, and preparations containing attenuated microorganisms | |
AU5985198A (en) | Enamel compositions, process for their preparation and their use | |
AU3444899A (en) | Method for the rapid determination of bacteria | |
AU5218398A (en) | Compositions for treating soils, method of preparation and use thereof | |
AU2002239258A1 (en) | Houttuyninum compositions and methods for inhibiting the activity of erbb-2 based thereon | |
AU2970299A (en) | Compositions and methods for polynucleotide delivery | |
AU7961498A (en) | 9a-azalides, compositions containing such compounds and methods of treatment | |
AU8898198A (en) | Methods of identifying biological agent compositions | |
AU1841195A (en) | 1-beta -methyl-carbapenem, compositions containing same and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |